Pre-mixed IV solutions: bags

Pre-mixed IV solutions: bags
Product Description

Premixed solutions in customized IV bags, sizes: 50, 100, 250, 500 and 1000 ml (one port, two ports, twist-off, luer valve)

Grifols Partnership is specialized in developing and manufacturing high quality sterile solutions in a wide range of containers made from a variety of materials in different sizes to suit every need in both the human and veterinary markets. Grifols Partnership offers any kind of sterile solution for injection for human or veterinary pharmaceutics, including products from our portfolio and products developed according to your needs.




Read more Show less

Grifols International, S.A.

  • ES
  • 2015
    On CPhI since
  • 4
    Certificates
  • 5000+
    Employees
View company profile
Sample request Get a quote
Categories
more categories Show less
Specifications
  • Selling Points
    Experienced Technicians; International Approvals/Standards; Product Features; Quality Service; Reputation
  • Supplied from
    Spain
  • Measured In
    piece
More specifications Fewer specifications
Sales Markets
Show more Show less

Grifols International, S.A.

  • ES
  • 2015
    On CPhI since
  • 4
    Certificates
  • 5000+
    Employees
View company profile

More Products from Grifols International, S.A.

  • Pre-mixed IV solutions: vials and bottles

    Product Pre-mixed IV solutions: vials and bottles

    Glass vials (5ml-50ml)Glass bottles (50ml-500ml)Grifols Partnership is specialized in developing and manufacturing high quality sterile solutions in a wide range of containers made from a variety of materials in different sizes to suit every need in both the human and veterinary markets. Grifols Partnership offers any kind of sterile solution for injection for human or veterinary pharmaceutics, including products from our portfolio and products developed according to your needs.
  • Water for Injection

    Product Water for Injection

    Because diluent is as important as your API, Grifols offers you Water for Injection Drug Master File (DMF)
  • 0,9% Sodium Chloride Injection USP

    Product 0,9% Sodium Chloride Injection USP

    Sodium Chloride 0,9% USPAvailable in flexible container 50mL, 100mL, 250mL, 500mL, 1000mL
show all products

Grifols International, S.A. resources

  • Video Grifols Partnership - Company presentation

    Grifols Partnership is a business to business contract development and manufacturing platform for sterile solutions (small molecules) and lipid emulsions with over 75 years of experience in producing high-quality intravenous solutions for the pharmaceutical industry worldwide.

    Wach our video and learn more about our services.

  • Whitepaper Supporting Small and emerging pharma through collaboration and specialized expertise

    Growth in the pharmaceutical industry is no longer exclusively driven by large pharmaceutical companies. The switch in the marketplace from a focus on blockbuster drugs to an emphasis on therapies that treat orphan and rare diseases has led to the rise of small and emerging pharma companies founded to advance novel medicines for specialized patient populations. These innovators require the support of contract service providers that recognize their unique requirements.

  • Whitepaper Catering to a growing demand for Small-volume parenteral manufacturing

    Drug candidates are becoming increasingly complex as manufacturers continue to focus on niche and personalized medicines. Contract development and manufacturing organizations with process and capacity, flexibility, and wide-ranging expertise in small-volume GMP manufacturing are needed to support efforts by pharma companies to rapidly bring these specialized products to the market.

  • Whitepaper Trends shaping the dynamic market for parenterals

    Demand for parenteral drugs continues to increase as the overall drug market expands and new therapies for both chronic and rare diseases enter the pipeline. Manufacturers are faced with increasing complexity, not only because of the drug substances, but also due to formulations, patient-centric delivery technologies,and regulatory requirements, which are all further complicated by abbreviated development timelines.

  • Brochure Grifols Partnership - Parenterals CDMO - Flyer

    Grifols Partnership is a contract development and manufacturing platform (CDMO) focused on added value injectable products, with a large, international experience in the development and manufacturing of many types of sterile drug products. We specialize in small molecule intravenous solutions and offer high quality pharmaceutical development and product manufacturing. Our portfolio also includes products which require careful design and assembly, including medical devices and bags for blood storage and collection.

  • Brochure Grifols Partnership - Parenterals CDMO

    Brochure describing Grifols Partnership services, products and capabilities offered to pharmaceutical companies. Featuring two FDA approved Manufacturing sites

  • Whitepaper The critical role of continous improvement in parenteral drug manufacturing

    In the competitive pharmaceutical manufacturing landscape, the ability to continuously achieve improvements in efficiency and productivity is essential to success. Given the higher complexity of parenteral drug manufacturing, continuously improving production processes is also paramount for ensuring the highest level of quality.

  • Brochure Grifols Partnership - Vial filling

    Grifols Partnership: your CMO for filling vials. Because diluent is as important as your API

  • Whitepaper Investing in Form-Fill-Seal technology

    Extensive process understanding is required to ensure the consistent manufacture of high-quality sterile parenteral products. At Grifols, our use of state-of-the-art automated aseptic processing systems, including form-fill-seal (FFS) technology, ensures control with minimal human intervention.

  • Brochure Rare specialist for tomorrow's medicines

    Rare specialist for tomorrow's medicines

Recommended products